TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2013: $2.78M2014: $3.37M2015: $2.47M2016: $2.55M$2.55M
2013Cost of Revenue (USD)2016
Fiscal YearCost of RevenueChange YoY
2016$2.55M+3.1%
2015$2.47M-26.6%
2014$3.37M+21.2%
2013$2.78M—